Cannabis preparations are gaining popularity among patients with various skin diseases. Due to the lack of scientific evidence, dermatologists remain cautious about their prescriptions. So far, only a few studies have been published about the effects of high-potency cannabis extracts on microorganisms (especially dermatophytes) causing skin problems that affect more than 25% of the worldwide population. Even though, the high-potency cannabis extracts prepared by cold extraction are mostly composed of non-psychoactive tetrahydrocannabinolic acid (THCA) and only low amount of THC, their use in topical treatment can be stigmatized. The in vitro antimicrobial and antifungal activity of two high potent cannabis strains extracted by three solvents traditionally or currently used by cannabis users (ethanol; EtOH, butane; BUT, dimethyl ether; DME) was investigated by broth dilution method. The chemical profile of cannabis was determined by high-performance liquid chromatography with ultraviolet detection and gas chromatography with mass spectrometer and flame ionization detector. The extraction methods significantly influenced chemical profile of extracts. The yield of EtOH extracts contained less cannabinoids and terpenes compared to BUT and DME ones. Most of the extracts was predominantly (>60%) composed of various cannabinoids, especially THCA. All of them demonstrated activity against 18 of the 19 microorganisms tested. The minimal inhibitory concentrations (MICs) of the extracts ranged from 4 to 256 μg/mL. In general, the bacteria were more susceptible to the extracts than dermatophytes. Due to the lower content of biologically active substances, the EtOH extracts were less effective against microorganisms. Cannabis extracts may be of value to treat dermatophytosis and other skin diseases caused by various microorganisms. Therefore, they could serve as an alternative or supportive treatment to commonly used antibiotics.

Department of Botany Faculty of Science Charles University Prague Czechia

Department of Food Science Czech University of Life Sciences Prague Prague Czechia

Zobrazit více v PubMed

Appendino G., Gibbons S., Giana A., Pagani A., Grassi G., Stavri M., et al. (2008). Antibacterial cannabinoids from PubMed DOI

Alves F. A. R., Morais S. M. de, Nogueira Sobrinho A. C., Silva I. N. G. da, Martins C. G., Silva A. A., et al. (2018). Chemical composition, antioxidant and antifungal activities of essential oils and extracts from DOI

Al-Zouabi I., Stogner J. M., Miller B. L., Lane E. S. (2018). Butane hash oil and dabbing: Insights into use, amateur production techniques, and potential harm mitigation. PubMed DOI PMC

Anastassov G. E., Changoer L., Van Damme P. A. (2019).

Anderson L. L., Low I. K., Banister S. D., McGregor I. S., Arnold J. C. (2019). Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome. PubMed DOI

Aqil M., Ahad A., Sultana Y., Ali A. (2007). Status of terpenes as skin penetration enhancers. PubMed DOI

Becker K., Heilmann C., Peters G. (2014). Coagulase-negative staphylococci. PubMed DOI PMC

Begum J., Mir N. A., Lingaraju M. C., Buyamayum B., Dev K. (2020). Recent advances in the diagnosis of dermatophytosis. PubMed DOI

Blaskovich M. A. T., Kavanagh A. M., Elliott A. G., Zhang B., Ramu S., Amado M., et al. (2021). The antimicrobial potential of cannabidiol. PubMed DOI PMC

Chan G. C. K., Hall W., Freeman T. P., Ferris J., Kelly A. B., Winstock A., et al. (2017). User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate. PubMed DOI

Cintosun A., Lara-Corrales I., Pope E. (2020). Mechanisms of Cannabinoids and Potential Alicability to Skin Diseases. PubMed DOI

CLSI (2008).

CLSI (2009).

Dahham S. S., Tabana Y. M., Iqbal M. A., Ahamed M. B., Ezzat M. O., Majid A. S., et al. (2015). The anticancer, antioxidant and antimicrobial properties of the sesquiterpene β-caryophyllene from the essential oil of PubMed DOI PMC

Danielli L. J., Pippi B., Duarte J. A., Maciel A. J., Lopes W., Machado M. M., et al. (2018). Antifungal mechanism of action of PubMed DOI

Daniulaityte R., Lamy F. R., Barratt M., Nahhas R. W., Martins S. S., Boyer E. W., et al. (2017). Characterizing marijuana concentrate users: A web-based survey. PubMed DOI PMC

Dhadwal G., Kirchhof M. G. (2018). The risks and benefits of cannabis in the dermatology. PubMed DOI

EFSA (2009). Scientific Opinion of the Panel on Food Contact Materials, Enzymes, Flavourings and Processing aids (CEF) on dimethyl ether as an extraction solvent.

EFSA (2015). Scientific Opinion on the safety of use of dimethyl ether as an extraction solvent under the intended conditions of use and the proposed maximum residual limits.

Farha M. A., MacNair C. R., Carfrae L. A., Zahed S. S. El, Ellis M. J., Tran H. R., et al. (2020). Uncovering the Hidden Antibiotic Potential of Cannabis. PubMed DOI

Fischedick J. T. (2017). Identification of Terpenoid Chemotypes Among High PubMed DOI PMC

Gallo-Molina A. C., Castro-vargas H. I., Garzón-méndez W. F., Ramírez J. A., Rivera Monroy Z. J., King J. W., et al. (2019). Extraction, isolation and purification of tetrahydrocannabinol from the DOI

Garrett E. R., Hunt C. A. (1974). Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol. PubMed DOI

Gnat S., Łagowski D., Nowakiewicz A. (2020). Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections. PubMed DOI

Han Y., Chen W., Sun Z. (2021). Antimicrobial activity and mechanism of limonene against DOI

Han Y., Sun Z., Chen W. (2020). Antimicrobial susceptibility and antibacterial mechanism of limonene against PubMed DOI PMC

Hashim P. W., Cohen J. L., Pompei D. T., Goldenberg G. (2017). Topical cannabinoids in dermatology. PubMed

Havlickova B., Czaika V. A., Friedrich M. (2008). Epidemiological trends in skin mycoses worldwide. PubMed DOI

Hay R. J., Johns N. E., Williams H. C., Bolliger I. W., Dellavalle R. P., Margolis D. J., et al. (2014). The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. PubMed DOI

Inoue Y., Shiraishi A., Hada T., Hamashima H. (2004). The Antibacterial Effects of Myrcene on Staphylococcus aureus and Its Role in the Essential Oil of the Tea Tree (Melaleuca alternifolia).

Iordache O., Cozea A., Vǎrzaru E., Stoica E., Platon C., Rodino S., et al. (2016). Antimicrobial activity of textiles treated with rosemary and orange essential oils against a selection of pathogenic fungi.

Janatová A., Fraňková A., Tlustoš P., Božik M., Klouček P. (2018). Yield and cannabinoids contents in different cannabis ( DOI

Johansson L., Thulin P., Low D. E., Norrby-Teglund A. (2010). Getting under the skin: The immunopathogenesis of PubMed DOI

LaVigne J. E., Hecksel R., Keresztes A., Streicher A. (2021). PubMed DOI PMC

Lewis M. A., Russo E. B., Smith K. M. (2018). Pharmacological Foundations of Cannabis Chemovars. PubMed DOI

Lim M., Kirchhof M. G. (2019). Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States. PubMed DOI

Mahmood F., Lim M. M., Kirchhof M. G. (2022). A Survey of Topical Cannabis Use in Canada. PubMed DOI

Martins A. M., Gomes A. L., Boas I. V., Marto J., Ribeiro H. M. (2022). Cannabis-based products for the treatment of skin inflammatory diseases: A timely review. PubMed DOI PMC

Orlando G., Adorisio S., Delfino D., Chiavaroli A., Brunetti L., Recinella L., et al. (2021). Comparative investigation of composition, antifungal, and anti-inflammatory effects of the essential oil from three industrial hemp varieties from Italian cultivation. PubMed DOI PMC

Orlando G., Recinella L., Chiavaroli A., Brunetti L., Leone S., Carradori S., et al. (2020). Water Extract from Inflorescences of Industrial Hemp Futura 75 Variety as a Source of Anti-Inflammatory, Anti-Proliferative and Antimycotic Agents: Results from In Silico, PubMed DOI PMC

Palmieri B., Laurino C., Vadala M. (2019). A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. PubMed DOI

Panda S., Verma S. (2017). The menace of dermatophytosis in India: The evidence that we need. PubMed DOI

Pasquali F., Schinzari M., Lucchi A., Mandrioli M., Toschi T. G., De Cesare A., et al. (2020). ‘Preliminary data on the antimicrobial effect of PubMed DOI PMC

Pepeljnjak S., Kosalec I., Kalodera Z., Blazević N. (2005). ‘Antimicrobial activity of juniper berry essential oil ( PubMed

Peschel W. (2016). Quality control of traditional Cannabis tinctures: Pattern, markers, and stability. PubMed DOI PMC

Pinto E., Hrimpeng K., Lopes G., Vaz S., Gonçalves M. J., Cavaleiro C., et al. (2013). Antifungal activity of Ferulago capillaris essential oil against PubMed DOI

Politi M., Peschel W., Wilson N., Prieto J. M., Heinrich M. (2008). Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on Δ9-THC and Δ9-THC-acid. PubMed DOI

Rajagopalan M., Inamadar A., Mittal A., Miskeen A. K., Srinivas C. R., Sardana K., et al. (2018). Expert consensus on the management of dermatophytosis in India (ECTODERM India). PubMed DOI PMC

Ramaraj V., Vijayaraman R. S., Rangarajan S., Kindo A. J. (2016). Incidence and prevalence of dermatophytosis in and around Chennai, Tamilnadu, India. DOI

Ranarivelo L. R., Randriamialinoro F., Rakotonandrasana S., Ratsimbason M., Vérité P., Lecso-Bornet M., et al. (2020). Chemical Composition and Antimicrobial Activity of Leaf Essential Oil of DOI

Romano L. L., Hazekamp A. (2013). Cannabis oil: Chemical evaluation of an upcoming cannabis- based medicine.

Russo E. B. (2011). Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. PubMed DOI PMC

Sanguinetti M., Posteraro B., Romano L., Battaglia F., Lopizzo T., De Carolis E., et al. (2007). PubMed DOI

Schofs L., Sparo M. D., Sánchez Bruni S. F. (2021). The antimicrobial effect behind PubMed DOI PMC

Schommer N. N., Gallo R. L. (2013). Structure and function of the human skin microbiome. PubMed DOI PMC

Singh A., Masih A., Khurana A., Singh P. K., Gupta M., Hagen F., et al. (2018). High terbinafine resistance in PubMed DOI

Singh P., Shukla R., Prakash B., Kumar A., Singh S., Mishra P. K., et al. (2010). ‘Chemical profile, antifungal, antiaflatoxigenic and antioxidant activity of PubMed DOI

Tavares A. C., Gonçalves M. J., Cruz M. T., Cavaleiro C., Lopes M. C., Canhoto J., et al. (2010). Essential oils from PubMed DOI

Turner C. E., Elsohly M. A. (1981). Biological activity of cannabichromene, its homologs and isomers. PubMed DOI

van Klingeren B., Ten Ham M. (1976). Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiol. PubMed DOI

Wang Y. H., Avula B., ElSohly M. A., Radwan M. M., Wang M., Wanas A. S., et al. (2018). Quantitative Determination of Δ 9 -THC, CBG, CBD, Their Acid Precursors and Five Other Neutral Cannabinoids by UHPLC-UV-MS. PubMed DOI

WHO (2019).

Zajicek J. P., Hobart J. C., Slade A., Barnes D., Mattison P. G. Musec Research Group et al. (2012). MUltiple sclerosis and extract of cannabis: Results of the MUSEC trial. PubMed DOI

Zuardi A. W. (2006). History of cannabis as a medicine: A review. PubMed DOI

Chitosan nanoparticles-encapsulated cannabis extracts and their antimicrobial potential against skin pathogens

Inhibitory Potential of Cannabis Biomass Extracts on Livestock-Associated Staphylococcal and Streptococcal Pathogens

Anti-staphylococcal activity of soilless cultivated cannabis across the whole vegetation cycle under various nutritional treatments in relation to cannabinoid content